Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001871327 | SCV002157047 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002361162 | SCV002666233 | uncertain significance | Cardiovascular phenotype | 2023-11-10 | criteria provided, single submitter | clinical testing | The p.W226S variant (also known as c.677G>C), located in coding exon 6 of the EMD gene, results from a G to C substitution at nucleotide position 677. The tryptophan at codon 226 is replaced by serine, an amino acid with highly dissimilar properties. Based on data from gnomAD, the C allele has an overall frequency of 0.002% (4/182759) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was 0.015% (2/81468) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |